A Phase 1b, Open-Label Study of CLN-978 for the Treatment of Active, Moderate to Severe Sjogren’s Disease

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521462-96-00

Acronym

CLN-978-SJ-101

Enrollment

Registered

2025-07-04

Start date

2025-08-05

Completion date

Unknown

Last updated

2025-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sjogren's Disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy

None listed

Source: EU CTIS · Data processed: Feb 4, 2026